You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MNPR Sale Disclosure
Robinson Chandler · SEC Form 4 · Filed Sep 28, 2026
Sale
Calculated transaction value
$744.5K
Robinson Chandler Chief Executive Officer
MNPR
Monopar Therapeutics
MNPR
Transaction date
Sep 24, 2026
Public filing date
Sep 28, 2026
Filing lag
Filed 4 days later
MNPR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,368 shares @ $88.97
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-031411
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$3.19M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monopar Therapeutics MNPR Current | Sale | Sep 24, 2026 | $744.5K |
| Monopar Therapeutics MNPR | Sale | Sep 24, 2026 | $910.72K |
| Monopar Therapeutics MNPR | Sale | Sep 24, 2026 | $847.76K |
| Monopar Therapeutics MNPR | Exercise | Sep 24, 2026 | $421.68K |
| Monopar Therapeutics MNPR | Sale | Sep 24, 2026 | $53.87K |
| Monopar Therapeutics MNPR | Exercise | Sep 24, 2026 | $0 |
| Monopar Therapeutics MNPR | Exercise | Sep 24, 2026 | $210K |
| Monopar Therapeutics MNPR | Exercise | Sep 24, 2026 | $0 |